XML 31 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Mar. 31, 2013
Mar. 28, 2013
Nov. 06, 2009
Mar. 31, 2013
ESPP
item
Nov. 09, 2010
ESPP
Mar. 31, 2013
Stock options
Dec. 31, 2012
Stock options
Mar. 31, 2013
Stock options
Minimum
Mar. 31, 2013
Stock options
Maximum
Mar. 31, 2013
Restricted shares
Stock-based compensation                    
Number of shares reserved for issuance     4,750,000   500,000          
Vesting period               3 years 4 years  
Expiration period           10 years        
Number of shares available for grant 455,381     486,099            
Number of Shares                    
Outstanding at the beginning of the period (in shares)           3,929,910        
Outstanding at the end of the period (in shares)           3,929,910 3,929,910      
Vested and exercisable at the end of the period (in shares)           2,651,513        
Vested and exercisable at the end of the period and expected to vest thereafter (in shares)           3,929,910        
Weighted-Average Exercise Price                    
Outstanding at the beginning of the period (in dollars per share)           $ 9.03        
Outstanding at the end of the period (in dollars per share)           $ 9.03 $ 9.03      
Vested and exercisable at the end of the period (in dollars per share)           $ 11.37        
Vested and exercisable at the end of the period and expected to vest thereafter (in dollars per share)           $ 9.03        
Weighted-Average Remaining Contractual Term (in years)                    
Outstanding at the end of the period           7 years 6 months 7 years 9 months      
Vested and exercisable at the end of the period           6 years 7 months 17 days        
Vested and exercisable at the end of the period and expected to vest thereafter           7 years 6 months        
Weighted-Average Grant-Date Fair Value                    
Outstanding (in dollars per share)           $ 3.84 $ 3.84      
Vested and exercisable at the end of the period (in dollars per share)           $ 4.59        
Vested and exercisable at the end of the period and expected to vest thereafter (in dollars per share)           $ 3.84        
Aggregate Intrinsic Value                    
Outstanding at the beginning of the period           $ (26,959)        
Outstanding at the end of the period           (26,959) (26,959)      
Vested and exercisable at the end of the period           (24,394)        
Vested and exercisable at the end of the period and expected to vest thereafter           (26,959)        
Stock-based compensation, additional disclosure                    
Closing stock price (in dollars per share)   $ 2.17                
Number of units                    
Unvested at the beginning of the period (in shares)                   128,060
Vested (in shares)                   (4,626)
Unvested at the end of the period (in shares)                   123,434
Expected to vest at the end of the period (in shares)                   123,434
Weighted-Average Grant-Date Fair Value                    
Unvested at the beginning of the period (in dollars per share)                   $ 7.46
Vested (in dollars per share)                   $ 8.11
Unvested at the end of the period (in dollars per share)                   $ 7.44
Expected to vest at the end of the period (in dollars per share)                   $ 7.44
Unrecognized compensation cost                    
Unrecognized compensation cost           2,294       623
Weighted-average remaining vesting period of recognition           1 year       1 year 8 months 12 days
2010 ESPP                    
Discount rate (as a percent)       10.00%            
Number of Offering periods       4            
Stock-based compensation expense       $ 1            
Shares available for purchase 455,381     486,099